Source: Virtual Congress 2020 – COPD phenotypes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Liška (Zagreb, Croatia), A. Vidakovic (Zagreb, Croatia), I. Rako (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia). Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD?. 2447

Member's Comments

No comment yet.

Related content which might interest you: Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters Source: Eur Respir J 2005; 26: Suppl. 49, 297s Year: 2005 Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree Source: Eur Respir J 2001; 18: Suppl. 33, 210s Year: 2001 Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008 Factors associated with poor prognostic outcome in acute exacerbation of COPD Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma Source: Eur Respir J 2006; 28: Suppl. 50, 122s Year: 2006 Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Predicting treatment outcomes following an exacerbation of airways disease Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Clinical parameters for predicting 3-month FEV1 response of obstructive lung diseases in elderly patients Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Effect of comorbidities on severity and clinical parameters of COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Clinical features and functional parameters predict the probability of ACO in patients with asthma and COPD Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Can asthma severity be a predictor of exacerbation severity? Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012